Apo-Imipramine

Apo-Imipramine: Antidepressant to fight depression

Apo-Imipramine is a drug belonging to a group of antidepressants known as non-selective neuronal uptake inhibitors. It is used to treat various forms of depression and other mental disorders. In this article we will look at the main aspects of Apo-Imipramine, including its country of origin, manufacturers, dosage forms, composition, indications for use, contraindications, side effects, interactions with other drugs, overdose, special instructions and literature sources.

Apo-Imipramine is manufactured by Apotex Inc. in Canada and Vector in Russia. Its international name is Imipramine. Also known by various synonyms including Depsonil, Imisin, Impramin, Melipramin, Priloigan 10 and Priloigan 25. The dosage form of Apo-Imipramine includes tablets of different dosages: 10 mg, 25 mg, 50 mg and 75 mg. The active ingredient of the drug is imipramine.

Apo-Imipramine is used to treat depressive conditions of various etiologies, including asthenodepressive syndrome, depression, depressive conditions in psychopathy and neuroses, as well as functional enuresis in children.

However, there are a number of contraindications to the use of Apo-Imipramine. It is not recommended for people with hypersensitivity to the drug, suffering from coronary heart disease, tachycardia, congestive heart failure, early post-infarction period, hepatic-renal failure, tendency to seizures, schizophrenia, epilepsy, glaucoma, prostate adenoma, bladder atony, pregnant women and children under 2 years of age.

Side effects of Apo-Imipramine may include headache, dizziness, incoordination, sleep disturbance, agitation, hallucinations, excessive sedation, paresthesia, tremor, convulsions, dysarthria, dry mouth, constipation, hepatitis, tachycardia, arrhythmia, orthostatic hypotension, retention urination, accommodation disturbance, leukocytosis or leukopenia, agranulocytosis, gynecomastia, galactorrhea, decreased libido, impotence and weight changes.

The interaction of Apo-Imipramine with other drugs can be significant. It may enhance the depressant effect of alcohol and other centrally acting drugs. It is also important to consider possible interactions with monoamine oxidase inhibitors (MAOIs), adrenergic blockers, antihistamines, anticholinergics and other antidepressants.

In case of overdose of Apo-Imipramine, serious poisoning may occur. Symptoms of overdose include seizures, cardiac arrhythmias, hyperpyrexia, hypertension, hypotension, respiratory distress, coma, and death. If you suspect an overdose, you should immediately seek medical help.

Before starting treatment with Apo-Imipramine, you must consult a doctor and follow his recommendations. It is important to follow the indicated dosages and regularly monitor the patient's condition during treatment. If side effects occur, you should inform your doctor.

This article provides general information about Apo-Imipramine and is not a substitute for consultation with a medical professional. Always ask your doctor or pharmacist for more information about your drug, its uses and possible risks.